Literature DB >> 14751083

New antiangiogenic agents for renal cell carcinoma: bevacizumab.

Ronald M Bukowski1.   

Abstract

Entities:  

Year:  2004        PMID： 14751083     DOI： 10.1007/s11912-004-0017-2

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


× No keyword cloud information.
  2 in total

Review 1.  Combination therapy for renal cell cancer: what are possible options?

Authors:  Napoleon Santos; Justin B Wenger; Pamela Havre; Yanxia Liu; Roi Dagan; Iman Imanirad; Alison M Ivey; Robert A Zlotecki; Chester B Algood; Scott M Gilbert; Carmen J Allegra; Paul Okunieff; Johannes Vieweg; Nam H Dang; Hendrik Luesch; Long H Dang
Journal:  Oncology       Date:  2011-11-12       Impact factor: 2.935

2.  Can we develop effective combination antiangiogenic therapy for patients with hepatocellular carcinoma?

Authors:  Justin B Wenger; Napoleon Santos; Yanxia Liu; Jennifer Dallas; Sukanthini Subbiah; Steven Hochwald; Emina H Huang; Duyen T Dang; Carmen J Allegra; Hendrik Luesch; Long H Dang
Journal:  Oncol Rev       Date:  2011-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.